Astranis

Astranis is an space company, developer of a satellite technology that aims to transmit data down to specific terrestrial locations.

Headquarters

Year Founded

Search Tags

Satellite Internet Technology, Geostationary Broadband Services, Telecommunications Satellite Solutions

About Us

Astranis creates small, advanced satellites for high orbit, that provide high-speed internet to regions with limited telecommunications infrastructure. The company develops compact geostationary satellites capable of delivering dedicated broadband services to underserved areas globally. Using innovative software-defined radio technology, Astranis builds lightweight satellites that can be launched quickly and cost-effectively, connecting millions of people who currently lack reliable internet access. Their satellites support commercial and government telecommunications needs, offering flexible bandwidth solutions across multiple international markets.

Trending Companies

Latest Articles

Engineer intelligent, AI-driven supply chain operations. Discover what next-generation leaders must master to design resilient, data-driven, high-performing global networks.

The Future of Supply Chain Leadership: Why the Next Generation Will Engineer Intelligence, Not Just Manage It

Supply chain leadership is being redefined by AI, intelligent automation, and agentic decision-making, demanding leaders who can engineer end-to-end intelligence rather than simply manage workflows. This article explores how next-generation supply chain leaders will combine data, algorithms, and human judgment to build resilient, adaptive, and high-performing global operations.

Read More >
Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >